Dapivirine Gel Rectal Safety and PK Study

NCT03044379 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Current program is on hold, not for safety reason

Conditions

HIV 1 Infection

Interventions

DRUG: Dapivirine gel (0.05%)
OTHER: Universal HEC placebo gel

Sponsor

International Partnership for Microbicides, Inc.